4.6 Article

Surface Phenotype and Functionality of WNV Specific T Cells Differ with Age and Disease Severity

期刊

PLOS ONE
卷 5, 期 12, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0015343

关键词

-

资金

  1. National Institutes of Health [HHSN266200400027C, 1U01AI082057-01, N01-AI-40066]

向作者/读者索取更多资源

West Nile virus (WNV) infection can result in severe neuroinvasive disease, particularly in persons with advanced age. As rodent models demonstrate that T cells play an important role in limiting WNV infection, and strong T cell responses to WNV have been observed in humans, we postulated that inadequate antiviral T cell immunity was involved in neurologic sequelae and the more severe outcomes associated with age. We previously reported the discovery of six HLA-A*0201 restricted WNV peptide epitopes, with the dominant T cell targets in naturally infected individuals being SVG9 (Env) and SLF9 (NS4b). Here, memory phenotype and polyfunctional CD8(+) T cell responses to these dominant epitopes were assessed in 40 WNV seropositive patients displaying diverse clinical symptoms. The patients' PBMC were stained with HLA-I multimers loaded with the SVG9 and SLF9 epitopes and analyzed by multicolor flow cytometry. WNV-specific CD8(+) T cells were found in peripheral blood several months post infection. The number of WNV-specific T cells in older individuals was the same, if not greater, than in younger members of the cohort. WNV-specific T cells were predominantly monofunctional for CD107a, MIP-1 beta, TNF alpha, IL-2, or IFN gamma. When CD8(+) T cell responses were stratified by disease severity, an increased number of terminally differentiated, memory phenotype (CD45RA(+) CD27(-) CCR7(-) CD57(+)) T cells were detected in patients suffering from viral neuroinvasion. In conclusion, T cells of a terminally differentiated/cytolytic profile are associated with neuroinvasion and, regardless of age, monofunctional T cells persist following infection. These data provide the first indication that particular CD8(+) T cell phenotypes are associated with disease outcome following WNV infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis

Ashley M. Snyder, Adelheid U. Brandenberger, Vanina L. Taliercio, Bianca E. Rich, Lisa B. Webber, Abram P. Beshay, Joshua E. Biber, Rachel Hess, Jamie L. W. Rhoads, Aaron M. Secrest

Summary: Chronic inflammatory skin diseases like AD and psoriasis not only impact patients' quality of life but also affect the QOL of their family members. This study reveals that these diseases can affect family members' lifestyle, emotions, and relationships with their loved ones.

INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE (2023)

Article Dermatology

Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology

Ashley M. Snyder, Suephy C. Chen, Mary-Margaret Chren, Laura K. Ferris, LaVar D. Edwards, Robert A. Swerlick, Nicholas D. Flint, Amy M. Cizik, Rachel Hess, Jacob Kean, Aaron M. Secrest

Summary: With the increasing availability of disease- and symptom-specific measures and the proven usefulness of patient-reported outcome measures (PROMs), the routine use of PROMs in clinical care is now possible. PROMs can enhance healthcare efficiency, improve the clinician-patient relationship, and increase patient satisfaction. However, there are barriers to overcome, such as the cost of implementing the technology, selecting appropriate PROMs for different diseases, and helping patients and clinicians understand the value of PROMs. Recommendations are provided to assist dermatologists in incorporating PROMs into their practices.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)

Article Medicine, Research & Experimental

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

Oriol Mitja, Gilmar Reis, David R. Boulware, Adam M. Spivak, Ammar Sarwar, Christine Johnston, Brandon Webb, Michael D. Hill, Davey Smith, Peter Kremsner, Marla Curran, David Carter, Jim Alexander, Marc Corbacho, Todd C. Lee, Katherine Huppler Hullsiek, Emily G. McDonald, Rachel Hess, Michael Hughes, Jared M. Baeten, Ilan Schwartz, Luanne Metz, Lawrence Richer, Kara W. Chew, Eric Daar, David Wohl, Michael Dunne

Summary: This study conducted a pooled analysis of individual participant data from 11 randomized controlled trials to evaluate the efficacy of hydroxychloroquine (HCQ) in outpatients with mild COVID-19. The results suggest that HCQ does not show significant effects on viral clearance and hospitalization rate, and therefore, the use of HCQ in mild COVID-19 outpatients should be discontinued to reduce the risk of disease progression.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Endocrinology & Metabolism

Impact of electronic health record-coaching features in weight change: A secondary analysis from the MAINTAIN-pc randomized trial

Maribel Cedillo, Polina V. V. Kukhareva, Skylar M. M. Larsen, Kathleen M. M. McTigue, Cindy L. L. Bryce, Bethany Barone Gibbs, Rachel Hess, Kimberly Huber, Molly B. B. Conroy

Summary: The study found that coaching interventions delivered through electronic health records (EHR) had a positive effect on weight management. The results also showed that participants who were satisfied with EHR delivery and felt a strong connection to their coach had better weight maintenance. On the other hand, participants whose needs were not met by the intervention, such as in-person support in a group or individual setting, experienced more weight regain.

OBESITY (2023)

Article Cell & Tissue Engineering

Constitutive expression of interleukin-27 diminishes proinflammatory cytokine production without impairing effector function of engineered T cells

Arya Afsahi, Rebecca Burchett, Christopher L. Baker, Allyson E. Moore, Jonathan L. Bramson

Summary: We engineered T cells to express recombinant single-chain IL-27 and a synthetic antigen receptor, and found that IL-27-expressing T cells sustained anti-tumor immunity and cytotoxicity while reducing pro-inflammatory cytokines. IL-27-expressing T cells may provide a potential avenue to avoid treatment-related toxicities commonly associated with engineered T-cell therapy.

CYTOTHERAPY (2023)

Article Cell & Tissue Engineering

T-cell engineered with a fully humanized B-cell maturation antigen- specific T-cell antigen coupler receptor effectively target multiple myeloma

Ksenia Bezverbnaya, Joanne A. Hammill, Derek Cummings, Bojana Bojovic, Bella Groisman, Christopher L. Baker, Craig Aarts, Danielle L. Hayes, Donna Rill, Stacey X. Xu, Andreas G. Bader, Christopher W. Helsen, Jonathan L. Bramson

Summary: B-cell maturation antigen (BCMA) is a clinically validated target for multiple myeloma. The authors have developed a fully humanized BCMA-specific T-cell antigen coupler (TAC) receptor. Optimization of the BCMA-specific TAC receptor was achieved through iterations of the BCMA-TAC design.

CYTOTHERAPY (2023)

Article Medicine, General & Internal

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection

Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, Emily B. Levitan, Bruce Levy, Grace A. McComsey, Lisa McCorkell, Girish N. Nadkarni, Sairam Parthasarathy, Upinder Singh, Tiffany A. Walker, Caitlin A. Selvaggi, Daniel J. Shinnick, Carolin C. M. Schulte, Rachel Atchley-Challenner, Leora I. Horwitz, Andrea S. Foulkes

Summary: SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms or other health effects occurring after acute infection, known as postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID. This study developed a definition of PASC based on self-reported symptoms and described the frequencies of PASC across cohorts, vaccination status, and number of infections.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Multidisciplinary Sciences

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

Leora I. Horwitz, Tanayott Thaweethai, Shari B. Brosnahan, Mine S. Cicek, Megan L. Fitzgerald, Jason D. Goldman, Rachel Hess, S. L. Hodder, Vanessa L. Jacoby, Michael R. Jordan, Jerry A. Krishnan, Adeyinka O. Laiyemo, Torri D. Metz, Lauren Nichols, Rachel E. Patzer, Anisha Sekar, Nora G. Singer, Lauren E. Stiles, Barbara S. Taylor, Shifa Ahmed, Heather A. Algren, Khamal Anglin, Lisa Aponte-Soto, Hassan Ashktorab, Ingrid V. Bassett, Brahmchetna Bedi, Nahid Bhadelia, Christian Bime, Marie-Abele C. Bind, Lora J. Black, Andra L. Blomkalns, Hassan Brim, Mario Castro, James Chan, Alexander W. Charney, Benjamin K. Chen, Li Qing Chen, Peter Chen, David Chestek, Lori B. Chibnik, Dominic C. Chow, Helen Y. Chu, Rebecca G. Clifton, Shelby Collins, Maged M. Costantine, Sushma K. Cribbs, Steven G. Deeks, John D. Dickinson, Sarah E. Donohue, Matthew S. Durstenfeld, Ivette F. Emery, Kristine M. Erlandson, Julio C. Facelli, Rachael Farah-Abraham, Aloke V. Finn, Melinda S. Fischer, Valerie J. Flaherman, Judes Fleurimont, Vivian Fonseca, Emily J. Gallagher, Jennifer C. Gander, Maria Laura Gennaro, Kelly S. Gibson, Minjoung Go, Steven N. Goodman, Joey P. Granger, Frank L. Greenway, John W. Hafner, Jenny E. Han, Michelle S. Harkins, Kristine S. P. Hauser, James R. Heath, Carla R. Hernandez, On Ho, Matthew K. Hoffman, Susan E. Hoover, Carol R. Horowitz, Harvey Hsu, Priscilla Y. Hsue, Brenna L. Hughes, Prasanna Jagannathan, Judith A. James, Janice John, Sarah Jolley, S. E. Judd, Joy J. Juskowich, Diane G. Kanjilal, Elizabeth W. Karlson, Stuart D. Katz, J. Daniel Kelly, Sara W. Kelly, Arthur Y. Kim, John P. Kirwan, Kenneth S. Knox, Andre Kumar, Michelle F. Lamendola-Essel, Margaret Lanca, Joyce K. Lee-Iannotti, R. Craig Lefebvre, Bruce D. Levy, Janet Y. Lin, Brian P. Logarbo Jr, Jennifer K. Logue, Michele T. Longo, Carlos A. Luciano, Karen Lutrick, Shahdi K. Malakooti, Gail Mallett, Gabrielle Maranga, Jai G. Marathe, Vincent C. Marconi, Gailen D. Marshall, Christopher F. Martin, Jeffrey N. Martin, Heidi T. May, Grace A. McComsey, Dylan McDonald, Hector Mendez-Figueroa, Lucio Miele, Murray A. Mittleman, Sindhu Mohandas, Christian Mouchati, Janet M. Mullington, Girish N. Nadkarni, Erica R. Nahin, Robert B. Neuman, Lisa T. Newman, Amber Nguyen, Janko Z. Nikolich, Igho Ofotokun, Princess U. Ogbogu, Anna Palatnik, Kristy T. S. Palomares, Tanyalak Parimon, Samuel Parry, Sairam Parthasarathy, Thomas F. Patterson, Ann Pearman, Michael J. Peluso, Priscilla Pemu, Christian M. Pettker, Beth A. Plunkett, Kristen Pogreba-Brown, Athena Poppas, J. Zachary Porterfield, John G. Quigley, Davin K. Quinn, Hengameh Raissy, Candida J. Rebello, Uma M. Reddy, Rebecca Reece, Harrison T. Reeder, Franz P. Rischard, Johana M. Rosas, Clifford J. Rosen, Nadine G. Rouphael, Dwight J. Rouse, Adam M. Ruff, Christina Saint Jean, Grecio J. Sandoval, Jorge L. Santana, Shannon M. Schlater, Frank C. Sciurba, Caitlin Selvaggi, Sudha Seshadri, Howard D. Sesso, Dimpy P. Shah, Eyal Shemesh, Zaki A. Sherif, Daniel J. Shinnick, Hyagriv N. Simhan, Upinder Singh, Amber Sowles, Vignesh Subbian, Jun Sun, Mehul S. Suthar, Larissa J. Teunis, John M. Thorp Jr, Amberly Ticotsky, Alan T. N. Tita, Robin Tragus, Katherine R. Tuttle, Alfredo E. Urdaneta, P. J. Utz, Timothy M. VanWagoner, Andrew Vasey, Suzanne D. Vernon, Crystal Vidal, Tiffany Walker, Honorine D. Ward, David E. Warren, Ryan M. Weeks, Steven J. Weiner, Jordan C. Weyer, Jennifer L. Wheeler, Sidney W. Whiteheart, Zanthia Wiley, Natasha J. Williams, Juan P. Wisnivesky, John C. Wood, Lynn M. Yee, Natalie M. Young, Sokratis N. Zisis, Andrea S. Foulkes

Summary: The RECOVER-Adult study aims to comprehensively study the post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID, in US adults. This national cohort study will characterize the prevalence, symptoms, natural history, and risk factors of PASC. The results will inform public health, stimulate clinical trials, and expand treatment options.

PLOS ONE (2023)

Article Immunology

LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling

Arya Afsahi, Christopher M. M. Silvestri, Allyson E. E. Moore, Carly F. F. Graham, Kaylyn Bacchiochi, Martine St-Jean, Christopher L. L. Baker, Robert G. G. Korneluk, Shawn T. T. Beug, Eric C. C. LaCasse, Jonathan L. L. Bramson

Summary: The SMAC mimetic drug LCL161 enhances T cell function by inhibiting IAP proteins and activating the non-canonical NF-kappa B pathway. However, LCL161 does not improve T cell anti-tumor function when interacting with myeloma cells, possibly due to sensitization of T cells to Fas-mediated apoptosis.

FRONTIERS IN IMMUNOLOGY (2023)

Article Public, Environmental & Occupational Health

Rapid-cycle designs to adapt interventions for COVID-19 in safety-net healthcare systems

Chelsey R. Schlechter, Thomas J. Reese, Jennifer Wirth, Bryan Gibson, Kensaku Kawamoto, Tracey Siaperas, Alan Pruhs, Courtney Pariera Dinkins, Yue Zhang, Michael Friedrichs, Stephanie George, Cho Y. Lam, Joni H. Pierce, Emerson P. Borsato, Ryan C. Cornia, Leticia Stevens, Anna Martinez, Richard L. Bradshaw, Kimberly A. Kaphingst, Rachel Hess, Guilherme Del Fiol, David W. Wetter

Summary: Racial/ethnic minority, low socioeconomic status, and rural populations are disproportionately affected by COVID-19. Developing and evaluating interventions to address COVID-19 testing and vaccination among these populations are crucial. The rapid-cycle design and adaptation process, which includes assessing context, determining intervention components, and conducting iterative adaptations, can improve the relevance and timeliness of interventions for populations experiencing health inequities. Real-time data on COVID-19 policies, case rates, and healthcare system capacity can inform and guide adaptations to ensure interventions are relevant and timely for patients.

TRANSLATIONAL BEHAVIORAL MEDICINE (2023)

Article Microbiology

A Randomized Clinical Trial Testing Hydroxychloroquine for Reduction of SARS-CoV-2 Viral Shedding and Hospitalization in Early Outpatient COVID-19 Infection

Adam M. Spivak, Bradley J. Barney, Tom Greene, Richard Holubkov, Cody S. Olsen, Jordan Bridges, Raj Srivastava, Brandon Webb, Frances Sebahar, Ainsley Huffman, Christina F. Pacchia, J. Michael Dean, Rachel Hess

Summary: Early in the COVID-19 pandemic, hydroxychloroquine was considered as a potential early treatment to prevent clinical worsening. However, this study found that hydroxychloroquine did not significantly alter the natural history of early COVID-19 disease.

MICROBIOLOGY SPECTRUM (2023)

Article Cardiac & Cardiovascular Systems

Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablation

Brian Zenger, Haojia Li, T. Jared Bunch, Candice Crawford, James C. Fang, Christopher A. Groh, Rachel Hess, Leenhapong Navaravong, Ravi Ranjan, Jeff Young, Yue Zhang, Benjamin A. Steinberg

Summary: By analyzing a large amount of data, this study found that there is significant variability in the cost of atrial fibrillation (AF) ablation procedures due to different operators. Direct costs and other services (primarily anesthesia) account for the majority of the costs associated with AF ablations. This research is of great significance for reducing the cost of AF ablation procedures and improving cost effectiveness.

HEART RHYTHM O2 (2023)

Article Medicine, General & Internal

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection

Tanayott R. Thaweethai, Sarah E. Jolley, Elizabeth Karlson, Emily M. Levitan, Bruce Levy, Grace McComsey, Lisa S. McCorkell, Girish D. Nadkarni, Sairam E. Parthasarathy, Upinder J. Singh, Tiffany Walker, Caitlin W. Selvaggi, Daniel Shinnick, Carolin C. M. P. Schulte, Rachel M. Atchley-Challenner, Leora Horwitz, Andrea Foulkes

Summary: This study aims to develop a definition of postacute sequelae of SARS-CoV-2 infection (PASC) using self-reported symptoms and analyze the frequencies of PASC across different cohorts, vaccination status, and number of infections. The results show that PASC is associated with various symptoms and around 10% of participants were PASC positive at 6 months after infection.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Geriatrics & Gerontology

Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada

Jessica A. Breznik, Ahmad Rahim, Tara Kajaks, Megan Hagerman, Lucas Bilaver, Karen Colwill, Roaya M. Dayam, Anne -Claude Gingras, Chris P. Verschoor, Janet E. McElhaney, Jonathan L. Bramson, Dawn M. E. Bowdish, Andrew P. Costa

Summary: A longitudinal cohort study in nursing and retirement homes in Ontario, Canada, identified vaccine type, number of doses, and recent infection history as important factors for protection against Omicron variant infection in older adults.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2023)

Article Dermatology

Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance

Z. H. Hopkins, G. Kuceki, V. L. Taliercio, A. M. Snyder, G. J. Stoddard, K. C. Duffin, R. Hess, A. M. Secrest

Summary: This study evaluated the construct validity of Skindex-16 in patients with psoriasis and found a moderate correlation between Skindex-16 scores and clinician-reported outcome measure of disease severity. Severe discordance was rare and primarily observed in patients with clear skin but poor quality of life.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

暂无数据